Genetics of weight gain associated with antipsychotic medications;Genetik der antipsychotika-assoziierten gewichtszunahme

Nervenarzt

Volumn 80, Issue 5, 2009, Pages 556-563

  Muller D J ^a,b   Peter, C ^a   Puls, I ^a   Brandl, E J ^a   Lang, U E ^a   Gallinat, J ^a   Heinz, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antipsychotics; Genetics; Neuroleptics; Schizophrenia; Weight gain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORPROMAZINE; CLOZAPINE; CYTOCHROME P450 2D6; HISTAMINE; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN 2C RECEPTOR; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ADRENERGIC SYSTEM; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IMMUNE SYSTEM; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; COMORBIDITY; DEPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; OBESITY; RISK ASSESSMENT; RISK FACTORS; WEIGHT GAIN;

EID: 67349209486     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-008-2650-8     Document Type: Review

References (51)

1. Möller 2005 Eur Arch Psychiatry Clin Neurosci 255 190
2. Weiden 2004 Schizophr Res 66 51
3. Müller 2006 Pharmacogenomics 7 863
4. Müller 2004 Pharmacol Res 49 309
5. Nasrallah 2008 Mol Psychiatry 13 27
6. Zimmermann 2003 J Psychiatr Res 37 193
7. Aichhorn 2007 Nervenarzt 78 45
8. Wirshing 1999 J Clin Psychiatry 60 358
9. Kim 2007 Proc Nat Acad Sci USA 104 3456
10. Kirchheiner 2004 Mol Psychiatry 9 442
11. Kirkwood SC, Fu D-J, Mukhopadhyay N, Mustermann M (2005) Genome-wide association study for olanzapine treatment-emergent weight gain. Presentation at the Fourth Annual Pharmacogenetics in Psychiatry Meeting, New York, April 14-15th, 2005. Abstr Book pp 1-2
12. Ellingrod 2002 Psychiatr Genet 12 55
13. Lane 2006 J Clin Psychopharmacol 26 128
14. Heinz 2002 Eur Psychiatry 17 9
15. Kapur 2003 Prog Neuropsychopharmacol Biol Psychiatry 27 1081
16. Tecott 1995 Nature 374 542
17. Ellingrod 2005 Am J Med Genet B Neuropsychiatr Genet 134 76
18. Miller 2005 Am J Med Genet B Neuropsychiatr Genet 133 97
19. Reynolds 2003 Am J Psychiatry 160 677
20. Reynolds 2002 Lancet 359 2086
21. Templeman 2005 Pharmacogenet Genomics 15 195
22. De 2007 Int J Neuropsychopharmacol 10 697
23. Buckland 2005 Am J Psychiatry 162 613
24. Cannon 2004 Physiol Rev 84 277
25. Baak 2001 Obes Rev 2 3
26. Park 2006 Am J Med Genet B Neuropsychiatr Genet 141 394
27. Wang 2005 J Neural Transm 112 1463
28. Belfer 2005 J Hum Genet 50 12
29. Matsui-Sakata 2005 Drug Metab Pharmacokinet 20 368
30. Müller 2005 Neurosci Lett 379 81
31. Musil 2008 J Psychiatr Res 42 963
32. Siffert 1998 Nat Genet 18 45
33. Müller 2005 Eur Neuropsychopharmacol 15 525
34. Wang 2005 Pharmacogenet Genomics 15 743
35. Himmerich 2006 Eur Cytokine Netw 17 196
36. Pollmächer 2000 J Psychiatr Res 34 369
37. Basile VS, Masellis M, McIntyre RS et al (2001) Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 62 [Suppl 23]:45-66
38. Zai 2006 Psychopharmacology 188 171
39. Jin 2008 Schizophr Res 100 70
40. Meltzer 2003 Schizophr Res 59 19
41. Umbricht DS, Pollack S, Kane JM (1994) Clozapine and weight gain. J Clin Psychiatry 55 [Suppl B]:157-160
42. Pollmächer 2002 Nervenarzt 73 897
43. Ellingrod 2007 Psychopharmacol Bull 40 57
44. Zhang 2007 J Clin Psychopharmacol 27 246
45. Zhang 2003 Zhonghua Yi Xue Za Zhi 83 2119
46. Hoffstedt 2002 Horm Metab Res 34 355
47. Mammes 1998 Diabetes 47 487
48. Laske 2006 Nervenarzt 77 523
49. Egan 2003 Cell 112 257
50. Chagnon 2004 Mol Psychiatry 9 1067
51. Sullivan 2008 Mol Psychiatry 13 570